REVENUE MEMORANDUM CIRCULAR NO. 17-2022 issued on January 31, 2022 publishes the full text of letter from Undersecretary Charade B. Mercado-Grande of the Department of Health endorsing updates to the “List of VAT-Exempt Drugs and Vaccines Prescribed and Directly Used for COVID-19 Treatment” under Republic Act No. 11534 (CREATE Act), which now includes Molnupiravir 200 mg capsule with brand name Molnarz.